IASLC 18th World Congress on Lung Cancer

IASLC 18th World Congress on Lung Cancer

The 18th World Conference on Lung Cancer(WCLC) of the International Association for the Study of Lung Cancer (IASLC) will take place from October 15 – 18, 2017, in Yokohama, Japan.

With the motto “Synergy to Conquer Lung Cancer”, the Conference will capture the collaborative spirit with participants of medical doctors, scientists, nurses, health professionals, government officials, partners from the industry, health advocacy groups and patients all over the world.

Our editorial team is going to attend the WCLC event this year. It is great to announce that our publisher AME Publishing Company is sponsor of delegate bags for the congress.

With this great opportunity, we are excited to meet the editorial board members, guest editors, contributors, and readers of our journals and books, and report significant information of the congress to our readers. Please note that our exhibit booth “AME Publishing Company” stands at No.1212 in the exhibit hall (Figure 1).

Looking forward to meeting you on the grand event of October!

The link to the 18th World Conference on Lung Cancer(WCLC) : http://wclc2017.iaslc.org/conference-information/welcome-message/.lung ca

PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions

PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations Review finds evidence of gadolinium deposits in the brain after MRI body scans but no signs of harm

Beyond landscape: development of a major healing garden

Beyond landscape: development of a major healing garden

 

Beyond landscape: development of a major healing garden

T. Scott Rawlings

Healthcare Design Leader, Consultant to Payette, MA, USA

Correspondence to: T. Scott Rawlings. Healthcare Design Leader, Consultant to Payette, MA, USA. Email: krobichaud@payette.com.

This article has been originally published in the journal Cardiovascular Diagnosis and Therapy.


Abstract: Healthcare in China is expanding faster than anywhere else on the planet and the impact of multiple, mega-medical centers on their communities, their culture and their general way of life is substantial. Through the lens of a 5.5 million square foot hospital located in the Hunan Province of China, this article addresses the factors design teams must consider when integrating nature in to hospital design. The Fifth Xiangya Hospital, designed by Boston-based architecture firm Payette, features a major public park, which is fully integrated in to the hospital design. The public park serves as connective tissue for the medical complex, extending its role beyond that of a traditional healing garden and embraces a much deeper purpose for the overall hospital campus.

Keywords: Architectural design; healthcare

https://www.medizin.uni-tuebingen.de/uktmedia/Studierende/PDF_Archiv/PhD_Experimental_Medicine_T%C3%BCbingen.pdf

https://www.medizin.uni-tuebingen.de/uktmedia/Studierende/PDF_Archiv/PhD_Experimental_Medicine_T%C3%BCbingen.pdf

The Faculty of Medicine Tübingen is one of the top medical schools in Germany and is characterized by interdisciplinary, international and innovative research and teaching. We can look back at major advances in clinical and basic biomedical research, particularly in our primary research fields – neuroscience, immunology, oncology, infection biology, imaging science, biomedical engineering, diabetology and vascular medicine.

Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.

Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.

 

Eur Radiol. 2016 Nov 18. [Epub ahead of print]

Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.

Abstract

OBJECTIVES:

More than 3.5 million invasive coronary angiographies (ICA) are performed in Europe annually. Approximately 2 million of these invasive procedures might be reduced by noninvasive tests because no coronary intervention is performed. Computed tomography (CT) is the most accurate noninvasive test for detection and exclusion of coronary artery disease (CAD). To investigate the comparative effectiveness of CT and ICA, we designed the European pragmatic multicentre DISCHARGE trial funded by the 7th Framework Programme of the European Union (EC-GA 603266).

METHODS:

In this trial, patients with a low-to-intermediate pretest probability (10-60 %) of suspected CAD and a clinical indication for ICA because of stable chest pain will be randomised in a 1-to-1 ratio to CT or ICA. CT and ICA findings guide subsequent management decisions by the local heart teams according to current evidence and European guidelines.

RESULTS:

Major adverse cardiovascular events (MACE) defined as cardiovascular death, myocardial infarction and stroke as a composite endpoint will be the primary outcome measure. Secondary and other outcomes include cost-effectiveness, radiation exposure, health-related quality of life (HRQoL), socioeconomic status, lifestyle, adverse events related to CT/ICA, and gender differences.

CONCLUSIONS:

The DISCHARGE trial will assess the comparative effectiveness of CT and ICA.

KEY POINTS:

• Coronary artery disease (CAD) is a major cause of morbidity and mortality. • Invasive coronary angiography (ICA) is the reference standard for detection of CAD. • Noninvasive computed tomography angiography excludes CAD with high sensitivity. • CT may effectively reduce the approximately 2 million negative ICAs in Europe. • DISCHARGE addresses this hypothesis in patients with low-to-intermediate pretest probability for CAD.

KEYWORDS:

Adverse events; Angiography; Comparative effectiveness; Computed tomography; Invasive coronary angiography

PMID:
27864607
DOI:
10.1007/s00330-016-4620-z